≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Sequelae of hyperalimentation

MESH Endpoint Browser PheWeb

E4_HYPERALISEQ

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — E68
  • Cause of death: ICD-10 — E68

2 out of 7 registries used, show all original rules.

59

4. Check minimum number of events

None

59

5. Include endpoints

None

59

6. Filter based on genotype QC (FinnGen only)

59

Control definitions (FinnGen only)

Control exclude
E4_OBESITY_HYPER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
E65-E68
Name in latin
Sequelae hyperalimentationis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 324 197 127
Only index persons 306 189 117
Unadjusted period prevalence (%)
Whole population 0.00 0.01 0.00
Only index persons 0.01 0.01 0.00
Median age at first event (years)
Whole population - 49.24 58.24
Only index persons 52.05 48.89 57.17

-FinnGen-

Key figures

All Female Male
Number of individuals 59 39 20
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 51.35 48.06 57.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
58
Matched controls
578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E68
ICD-10 Finland
Sequelae of hyperalimentation
+∞
83.1
58
*
E66.01
ICD-10 Finland
Obesity due to excess calories
174.8
28.7
28
*
E66.8
ICD-10 Finland
Other obesity
+∞
27.2
24
*
E66.9
ICD-10 Finland
Obesity, unspecified
+∞
17.6
16
*
E66.00
ICD-10 Finland
Metabolic syndrome
78.3
15.8
17
*
QBJ30
NOMESCO Finland
Correction of abdominal apron
+∞
14.1
13
*
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
+∞
8.5
8
*
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
+∞
8.5
8
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
6.3
8.3
25
62
T82
ICPC
Obesity
14.7
6.9
11
9
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
16.9
6.7
10
7
103
Kela drug reimbursment
Diabetes, insulin-treated
4.6
6.3
25
82

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019309) Folate [Moles/volume] in Red Blood Cells
25
78
4.83
7.81
2.1
1.6
nmol/l
1061.7
1205.4
0.32
20
60
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
38
174
4.33
6.95
3.6
2.3
nmol/l
65.2
76.9
1.96
32
160
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
37
170
4.16
6.65
2.8
1.8
pmol/l
105.6
96.0
0.46
26
82
(3009508) Creatinine [Moles/volume] in Urine
29
114
4.04
6.48
4.9
2.8
mmol/l
6.8
8.0
0.60
22
99
(3020682) Albumin/Creatinine [Ratio] in Urine
29
116
3.95
6.29
6.0
3.5
mg/mmol
8.6
7.0
0.12
17
83
(3004789) Transferrin [Mass/volume] in Serum or Plasma
19
60
4.20
5.64
2.6
2.3
g/l
2.6
2.4
0.93
19
55
(3012516) Albumin [Mass/volume] in Urine
26
104
3.68
5.52
5.3
3.0
mg/l
71.3
36.0
0.33
16
74
(3022948) Iron [Moles/volume] in Serum or Plasma
20
67
4.00
5.47
2.8
2.2
umol/l
10.7
13.7
1.49
20
62
(3007853) Bacteria identified in Skin by Aerobe culture
15
43
4.34
5.00
5.9
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
31
4.60
4.51
1.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
13
36
4.35
4.49
8.5
6.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
39
229
3.07
4.05
5.8
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
30
155
2.90
3.90
3.0
2.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
33
182
2.85
3.77
5.1
7.1
inr
1.2
1.1
—
7
60
(3042936) Bacteria identified in Isolate by Culture
17
65
3.27
3.70
2.9
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
42
267
2.99
3.61
5.0
4.4
mmol/l
7.1
6.5
0.84
42
243
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
10
7.76
3.47
1.9
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
10
7.76
3.47
1.9
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
10
7.76
3.47
1.9
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
24
116
2.80
3.46
3.1
3.1
umol/l
332.9
5783.2
0.78
19
100
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
24
118
2.74
3.33
2.6
3.4
ng/l
1412.0
1697.5
0.13
19
103
(3023368) Bacteria identified in Blood by Culture
24
119
2.71
3.27
4.8
4.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
35
211
2.62
3.20
9.5
6.8
mmol/l
1.2
1.2
0.44
29
178
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
8
8.18
3.13
1.5
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
26
3.89
2.61
1.9
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
48
364
2.71
2.36
4.1
4.3
pmol/l
14.3
14.7
0.48
40
336
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
113
2.33
2.30
3.1
2.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
35
235
2.20
2.23
6.8
6.0
%
59.0
57.1
0.50
35
221
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
20
3.82
2.13
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
20
3.82
2.13
2.0
1.3
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
5
10
5.34
2.11
1.2
2.1
g/l
3.2
3.2
—
5
10
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
54
455
3.20
2.11
5.2
3.7
mmol/l
1.6
1.3
1.05
49
427
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
11
4.85
1.98
1.2
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
28
179
2.07
1.96
4.9
4.4
ng/l
94.3
34.2
0.54
21
113
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
23
3.31
1.86
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
12
4.44
1.86
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
14
69
2.35
1.83
1.1
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
6
18
3.59
1.79
1.0
1.4
g/l
0.3
0.2
—
6
18
(3020961) Endomysium IgA Ab [Titer] in Serum
6
18
3.59
1.79
1.0
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
33
230
1.99
1.77
7.4
6.2
%
2.8
2.7
0.10
33
214
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
49
397
2.38
1.72
9.0
8.0
u/l
89.9
75.1
1.56
49
375
(3019069) Monocytes/100 leukocytes in Blood
33
232
1.96
1.71
7.9
6.5
%
7.6
8.6
1.26
33
216
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
7
25
3.03
1.71
3.6
2.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
6
19
3.39
1.71
9.0
7.8
%
95.5
95.5
—
6
19
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
53
454
2.64
1.68
20.4
13.4
ml/min/173m2
82.9
82.9
0.00
47
377
(3000991) Gas panel - Venous blood
7
26
2.91
1.64
9.0
11.0
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
6
20
3.22
1.62
8.7
7.5
%
0.5
0.8
—
6
20
(3022313) Gas panel - Capillary blood
6
20
3.22
1.62
13.2
3.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
16
3.31
1.47
1.2
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
41
325
1.86
1.33
5.0
4.2
—
—
—
0
0
(3013512) EKG study
21
136
1.84
1.33
5.7
4.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
5
18
2.94
1.31
1.0
1.4
g/l
1.5
1.0
—
5
18
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
5
19
2.78
1.24
7.6
7.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
26
2.45
1.22
1.2
1.2
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
20
2.63
1.17
10.6
7.5
%
0.8
1.3
—
5
20
(3012544) pH of Venous blood
7
32
2.34
1.12
4.0
6.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
30
225
1.68
1.11
7.8
6.1
%
0.7
0.7
0.10
30
208
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
165
1.65
0.99
3.9
3.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
6
29
2.19
0.92
1.0
2.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
21
152
1.59
0.85
3.0
3.0
e6/l
13.9
431.0
0.50
15
119
(42870588) Differential panel, method unspecified - Blood
22
162
1.57
0.83
7.2
5.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
8
48
1.77
0.82
7.8
5.5
mmol/l
0.6
1.6
—
8
32
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
11
67
1.79
0.82
2.9
2.6
e6/l
10.4
2.9
—
5
36
(3022145) Colonoscopy Study observation
9
54
1.78
0.79
1.1
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
23
2.28
0.78
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
14
196
0.63
0.74
4.2
2.6
—
—
—
0
0
(4035726)
7
40
1.85
0.74
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
5
28
1.86
0.68
1.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
50
1.69
0.65
4.1
3.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
51
1.66
0.64
1.6
1.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
18
134
1.49
0.63
3.3
3.0
e6/l
0.2
0.4
0.59
13
101
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
61
1.56
0.57
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
18
137
1.45
0.56
3.3
2.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
51
474
1.56
0.52
6.1
4.0
mmol/l
6.7
5.8
2.56
46
439
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
49
1.49
0.48
4.3
7.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
49
452
1.50
0.47
24.3
13.0
%
38.9
40.2
0.53
37
351
(3000494) Fungus identified in Specimen by Culture
7
50
1.45
0.47
1.4
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
10
71
1.49
0.42
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9
121
0.70
0.40
5.3
5.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
17
136
1.35
0.39
2.3
2.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
21
175
1.31
0.37
3.9
3.4
e6/l
14.7
39.8
0.94
15
122
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7
51
1.42
0.33
1.9
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
7
52
1.39
0.33
2.7
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
10
75
1.40
0.33
1.8
1.7
—
—
—
0
0
(3015736) pH of Urine
21
178
1.28
0.32
3.1
3.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
94
1.35
0.31
1.5
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
16
132
1.29
0.30
1.7
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
54
520
1.45
0.28
26.5
15.8
umol/l
75.6
75.3
0.02
54
520
(3002385) Erythrocyte distribution width [Ratio]
39
418
0.80
0.27
26.6
16.7
%
14.3
13.5
2.62
39
411
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
106
1.29
0.26
2.0
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
26
234
1.20
0.22
4.7
5.2
estimate
0.0
0.0
—
5
54
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
11
0.00
0.21
0.0
2.5
—
5.8
—
0
11
(3014051) Protein [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
1.9
—
0.5
—
0
6
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
12
0.00
0.21
0.0
4.1
—
62.0
—
0
12
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
16.9
—
0
13
(36660697) Celiac disease serology panel - Serum
6
49
1.25
0.21
1.3
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
6
52
1.17
0.20
3.2
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
26
236
1.18
0.19
3.3
3.8
estimate
0.0
0.0
—
6
50
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
59
1.21
0.19
2.0
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
12
102
1.22
0.17
2.7
3.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6
78
0.74
0.17
1.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
10
84
1.23
0.15
1.5
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
16
178
0.86
0.13
3.4
4.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
25
232
1.13
0.12
3.0
3.8
estimate
0.0
0.0
—
5
52
(40768804) Tissue Pathology biopsy report
22
203
1.13
0.12
2.5
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
35
333
1.13
0.11
4.0
3.6
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
11
124
0.86
0.10
3.6
4.0
estimate
0.0
0.0
—
5
54
(3041096) Erythrocytes [Presence] in Urine by Automated
13
144
0.88
0.09
3.2
3.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
5
48
1.05
0.09
4.2
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
32
330
0.93
0.04
4.3
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
13
125
1.05
0.00
7.1
7.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
59.0
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
118.4
—
0
7
(40768795) Lymph node Pathology biopsy report
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
252.0
—
0
5
(4268621)
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
6
60
1.00
0.00
1.2
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
0
5
0.00
0.00
0.0
17.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.0
—
105.3
—
0
6
(3035637) Corticotropin [Mass/volume] in Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(4306422)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
93.2
—
0
6
(3041354) Potassium [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
3.0
—
3.9
—
0
6
(3042631) Mycobacterium sp identified in Specimen
0
8
0.00
0.00
0.0
4.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
8
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
0
7
0.00
0.00
0.0
1.1
—
91.6
—
0
7
(3017569) Oxygen content in Arterial blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
0
9
0.00
0.00
0.0
2.7
—
7.7
—
0
9
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
6.4
—
159.4
—
0
7
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
1.9
—
230.1
—
0
8
(3025130) Human papilloma virus identified in Specimen
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
2.3
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
8
0.00
0.00
0.0
3.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
5
0.00
0.00
0.0
4.0
—
34.0
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
24.6
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPERALISEQ and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have E4_HYPERALISEQ.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: E4_HYPERALISEQ – Sequelae of hyperalimentation

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data